BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2454327)

  • 1. Androgen concentration in blacks with benign and malignant prostatic disease.
    Osegbe DN; Ogunlewe JO
    J Urol; 1988 Jul; 140(1):160-4. PubMed ID: 2454327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
    Ogunlewe JO; Osegbe DN
    Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.
    Hammond GL
    J Endocrinol; 1978 Jul; 78(1):7-19. PubMed ID: 79632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of steroids on oxytocin secretion by the human prostate in vitro.
    Assinder SJ; Nicholson HD
    Int J Androl; 2004 Feb; 27(1):12-8. PubMed ID: 14718041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
    Habib FK; Lee IR; Stitch SR; Smith PH
    J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    Bard DR; Lasnitzki I
    J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
    Monti S; Di Silverio F; Toscano V; Martini C; Lanzara S; Varasano PA; Sciarra F
    J Androl; 1998; 19(4):428-33. PubMed ID: 9733145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
    Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
    Yang Y; Chisholm GD; Habib FK
    Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered metabolism of androgens in elderly men with benign prostatic hyperplasia.
    Ishimaru T; Pages L; Horton R
    J Clin Endocrinol Metab; 1977 Oct; 45(4):695-701. PubMed ID: 72074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
    Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen of the human prostate.
    Farnsworth WE; Brown JR
    Endocr Res Commun; 1976; 3(2):105-17. PubMed ID: 60232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
    Klein H; Bressel M; Kastendieck H; Voigt KD
    Am J Clin Oncol; 1988; 11 Suppl 2():S30-6. PubMed ID: 2853935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.